Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Wirth

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
European Urology|November 27, 2010
Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in EuropeChristopher R Chapple, Francesco Montorsi, Teuvo L J Tammela, et al.
Journal of Computer Assisted Tomography|May 5, 2015
Multiparametric Prostate Magnetic Resonance Imaging at 3 T: Failure of Magnetic Resonance Spectroscopy to Provide Added ValueIvan Platzek, Angelika Borkowetz, Marieta Toma, et al.
European Urology|July 17, 2013
Early detection of prostate cancer: European Association of Urology recommendationAxel Heidenreich, Per-Anders Abrahamsson, Walter Artibani, et al.
Virology Journal|August 29, 2014
Identification of molecular sub-networks associated with cell survival in a chronically SIVmac-infected human CD4+ T cell lineFeng Q He, Ulrike Sauermann, Christiane Beer, et al.
World Journal of Urology|May 23, 2014
Decision curve analysis and external validation of the postoperative Karakiewicz nomogram for renal cell carcinoma based on a large single-center study cohortStefan Zastrow, Sabine Brookman-May, Thi Anh Phuong Cong, et al.
The Prostate|January 15, 2009
Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acidMichael Lein, Kurt Miller, Manfred Wirth, et al.
BJU International|December 20, 2014
Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancerAngelika Borkowetz, Ivan Platzek, Marieta Toma, et al.
European Urology|June 26, 2018
Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018Alberto Briganti, Nicola Fossati, James W F Catto, et al.
European Urology|December 23, 2018
Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease?Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al.
European Urology|August 19, 2021
Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021Hendrik Van Poppel, Monique J Roobol, Christopher R Chapple, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
European Urology|November 27, 2010
Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in EuropeChristopher R Chapple, Francesco Montorsi, Teuvo L J Tammela, et al.
Journal of Computer Assisted Tomography|May 5, 2015
Multiparametric Prostate Magnetic Resonance Imaging at 3 T: Failure of Magnetic Resonance Spectroscopy to Provide Added ValueIvan Platzek, Angelika Borkowetz, Marieta Toma, et al.
European Urology|July 17, 2013
Early detection of prostate cancer: European Association of Urology recommendationAxel Heidenreich, Per-Anders Abrahamsson, Walter Artibani, et al.
Virology Journal|August 29, 2014
Identification of molecular sub-networks associated with cell survival in a chronically SIVmac-infected human CD4+ T cell lineFeng Q He, Ulrike Sauermann, Christiane Beer, et al.
World Journal of Urology|May 23, 2014
Decision curve analysis and external validation of the postoperative Karakiewicz nomogram for renal cell carcinoma based on a large single-center study cohortStefan Zastrow, Sabine Brookman-May, Thi Anh Phuong Cong, et al.
The Prostate|January 15, 2009
Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acidMichael Lein, Kurt Miller, Manfred Wirth, et al.
BJU International|December 20, 2014
Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancerAngelika Borkowetz, Ivan Platzek, Marieta Toma, et al.
European Urology|June 26, 2018
Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018Alberto Briganti, Nicola Fossati, James W F Catto, et al.
European Urology|December 23, 2018
Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease?Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al.
European Urology|August 19, 2021
Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021Hendrik Van Poppel, Monique J Roobol, Christopher R Chapple, et al.
Pageof 10